JP2002525313A5 - - Google Patents

Download PDF

Info

Publication number
JP2002525313A5
JP2002525313A5 JP2000571896A JP2000571896A JP2002525313A5 JP 2002525313 A5 JP2002525313 A5 JP 2002525313A5 JP 2000571896 A JP2000571896 A JP 2000571896A JP 2000571896 A JP2000571896 A JP 2000571896A JP 2002525313 A5 JP2002525313 A5 JP 2002525313A5
Authority
JP
Japan
Prior art keywords
weight
enteric
composition
water
flake material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000571896A
Other languages
English (en)
Japanese (ja)
Other versions
JP4662634B2 (ja
JP2002525313A (ja
Filing date
Publication date
Priority claimed from US09/162,282 external-priority patent/US6139875A/en
Application filed filed Critical
Publication of JP2002525313A publication Critical patent/JP2002525313A/ja
Publication of JP2002525313A5 publication Critical patent/JP2002525313A5/ja
Application granted granted Critical
Publication of JP4662634B2 publication Critical patent/JP4662634B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000571896A 1998-09-29 1999-09-13 胃透過性の低い水性腸溶性被覆組成物 Expired - Fee Related JP4662634B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/162,282 1998-09-29
US09/162,282 US6139875A (en) 1998-09-29 1998-09-29 Aqueous enteric coating composition and low gastric permeability enteric coating
PCT/US1999/021072 WO2000018376A1 (en) 1998-09-29 1999-09-13 Aqueous enteric coating composition with low gastric permeability

Publications (3)

Publication Number Publication Date
JP2002525313A JP2002525313A (ja) 2002-08-13
JP2002525313A5 true JP2002525313A5 (https=) 2006-11-24
JP4662634B2 JP4662634B2 (ja) 2011-03-30

Family

ID=22584979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000571896A Expired - Fee Related JP4662634B2 (ja) 1998-09-29 1999-09-13 胃透過性の低い水性腸溶性被覆組成物

Country Status (5)

Country Link
US (1) US6139875A (https=)
EP (1) EP1117385B1 (https=)
JP (1) JP4662634B2 (https=)
DE (1) DE69928555T2 (https=)
WO (1) WO2000018376A1 (https=)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
KR100461566B1 (ko) * 2001-11-15 2004-12-14 삼성정밀화학 주식회사 수계 분산 히드록시프로필메틸 셀룰로오스 프탈레이트나노입자의 제조방법
SE0103839D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
KR100511086B1 (ko) * 2003-09-17 2005-08-30 삼성정밀화학 주식회사 장용성의 수계 분산 히드록시프로필 메틸셀룰로오스프탈레이트 나노입자의 제조방법
KR20050080626A (ko) * 2004-02-10 2005-08-17 삼성정밀화학 주식회사 수계분산 히드록시프로필 메틸셀룰로오스 프탈레이트나노입자 조성물의 제조방법
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
WO2006014973A2 (en) * 2004-07-26 2006-02-09 Teva Pharmaceutical Industries, Ltd. Pharmaceutical dosage forms including rasagiline
CA2617164A1 (en) * 2005-08-01 2007-02-08 Alpharma Inc. Alcohol resistant pharmaceutical formulations
CA2624897C (en) * 2005-10-12 2017-02-14 Proventiv Therapeutics, Llc Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
US20070092559A1 (en) * 2005-10-24 2007-04-26 Jinghua Yuan Liquid dosage forms having enteric properties of delayed and then sustained release
ES2593047T3 (es) 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
US8968799B2 (en) * 2006-09-01 2015-03-03 Rise-N-Shine L.L.C. Time delayed release mechanism for energizing composition and method of use
KR20190028822A (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
US8592401B2 (en) * 2007-04-25 2013-11-26 Proventiv Therapeutics, Llc Methods and compounds for vitamin D therapy
US11752158B2 (en) * 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
HUE073014T2 (hu) 2007-04-25 2025-12-28 Opko Renal Llc Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén
EP2281058B1 (en) 2008-04-02 2016-06-29 Opko Ireland Global Holdings, Ltd. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
EP2400839B1 (en) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2011032169A2 (en) * 2009-09-14 2011-03-17 Phusis Therapeutics Inc. Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
US20110217426A1 (en) * 2010-03-04 2011-09-08 Perry Stephen C Enteric coating composition
WO2011123476A1 (en) 2010-03-29 2011-10-06 Cytochroma Inc. Methods and compositions for reducing parathyroid levels
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2895162C (en) 2012-12-14 2021-03-09 D. Lynn Kirkpatrick Methods and compositions for inhibiting cnksr1
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
EP3125905A4 (en) 2014-04-04 2017-11-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CA2983260C (en) 2015-04-20 2024-01-23 Phusis Therapeutics, Inc. Sulfonamide compounds, compositions and methods for inhibiting cnksr1
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US20160331689A1 (en) 2015-05-12 2016-11-17 SE Tylose USA, Inc. Aqueous enteric coating composition
WO2017066134A1 (en) * 2015-10-16 2017-04-20 Merck Sharp & Dohme Corp. Processes for preparing formulations for gastrointestinal-targeted therapies
CN115252650A (zh) 2015-11-03 2022-11-01 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3473244A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
EP3473245A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
ES2920357T3 (es) 2017-11-10 2022-08-03 Nutrition & Biosciences Usa 4 Inc Polisacárido morfológico único
EP4467599A3 (en) 2017-12-14 2025-04-23 Nutrition & Biosciences USA 4, Inc. Alpha-1,3-glucan graft copolymers
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
FR3083545A1 (fr) 2018-07-04 2020-01-10 Institut National De La Recherche Agronomique Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
EP3870616B1 (en) 2018-10-25 2023-10-11 DuPont Industrial Biosciences USA, LLC Alpha-1,3-glucan graft copolymers
CA3116415A1 (en) 2018-11-05 2020-05-14 MarvelBiome, Inc. Microbial compositions comprising ellagitannin and methods of use
EP3986163A2 (en) 2019-06-19 2022-04-27 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
WO2021092228A1 (en) 2019-11-06 2021-05-14 Nutrition & Biosciences USA 4, Inc. Highly crystalline alpha-1,3-glucan
US11733011B2 (en) * 2020-11-24 2023-08-22 Raytheon Company Steering system with power take-off from actuators
CA3238788A1 (en) 2021-11-22 2023-05-25 Eric Michael Schott Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
WO2025064645A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating inflammatory bowel disease
WO2025064621A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating colorectal cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150111A (en) * 1974-05-28 1979-04-17 Allister Warren Enteric coated magnesium chloride
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5104922A (en) * 1990-10-22 1992-04-14 E. I. Du Pont De Nemours And Company Stable aqueous aluminum flake dispersion
JP2925346B2 (ja) * 1991-03-18 1999-07-28 田辺製薬株式会社 腸溶性製剤およびその製法
WO1995016451A1 (fr) * 1992-06-22 1995-06-22 Franck Arno Gouchet Comprimes a liberation controlee de 4-asa
US5330759A (en) * 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
JPH08109126A (ja) * 1994-10-07 1996-04-30 Amano Pharmaceut Co Ltd 耐衝撃性腸溶性顆粒剤およびこれを含有する錠剤
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5612397A (en) * 1994-12-19 1997-03-18 Rohm And Haas Company Composition having wet state clarity
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
JPH08333240A (ja) * 1995-06-02 1996-12-17 Shin Etsu Chem Co Ltd 粉末またはペレット状ワックスを用いる無溶媒腸溶性コーティング剤で被覆した腸溶性製剤
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
US5756008A (en) * 1996-08-14 1998-05-26 E. I. Du Pont De Nemours And Company Water cleanable silver composition

Similar Documents

Publication Publication Date Title
JP2002525313A5 (https=)
JP4662634B2 (ja) 胃透過性の低い水性腸溶性被覆組成物
JP3194974B2 (ja) 標的制御釈放薬剤
CA2382098C (en) Sustained-release, oral pharmaceutical forms of administration
JP4381479B2 (ja) ジルチアゼム除放性製剤
Siepmann et al. Blends of aqueous polymer dispersions used for pellet coating: importance of the particle size
Siepmann et al. Polymer blends for controlled release coatings
Sato et al. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method
CN102215827B (zh) 基于微粒的耐酒精缓释口服药物剂型
JP2007510677A (ja) 調節性の物質の放出に影響を及ぼすマトリックスを有する多層の剤形
Jain et al. Development and characterization of eudragit RS 100 loaded microsponges and its colonic delivery using natural polysaccharides
Junyaprasert et al. Release profile comparison and stability of diltiazem–resin microcapsules in sustained release suspensions
US20050152967A1 (en) Dynamic variable release
JPS56127322A (en) Enteric coating material composition for solid drug
CA2349696A1 (en) Controlled release formulation for water soluble drugs
HU203968B (en) Aqueous dispersions for coating drug forms
IL174561A (en) Drug coating that allows high drug release and methods for its preparation
KR20150132211A (ko) 칼슘 실리케이트를 포함하는 서방형 필름 코팅 및 이로 코팅된 기질
RU2011150228A (ru) Системы пленочного покрытия для препаратов с немедленным высвобождением, создающие усиленный барьер от влаги, и субстраты с таким покрытием
Kulkarni et al. Enteric delivery of ketoprofen through functionally modified poly (acrylamide-grafted-xanthan)-based pH-sensitive hydrogel beads: preparation, in vitro and in vivo evaluation
Kilor et al. Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using κ-carrageenan as a pelletizing agent
EP0559645A1 (en) Composition for solid pharmaceutical preparations containing active vitamins d 3? and process for preparation thereof
Basavaraj et al. HOLLOW MICROSPHERES OF DICLOFENAC SODIUM-A GASTRORETENTIVE CONTROLLED DELIVERY SYSTEM.
Lamprecht et al. Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release
JPS5942325A (ja) コ−テイング用組成物及びコ−テイング製剤